Home › Chronic Lymphocytic Leukemia › New York › Rochester
Chronic Lymphocytic Leukemia clinical trials in Rochester, NY
4 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
RecruitingPhase 3
- University of Rochester, Rochester
- Wilmot Cancer Institute at Webster, Webster · 10 mi away
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RecruitingPhase 3
- University of Rochester, Rochester
- Wilmot Cancer Institute at Webster, Webster · 10 mi away
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RecruitingPhase 3
- University of Rochester, Rochester
Impact of Targeted Therapy on Cancer-Related Cognitive Impairment
RecruitingObservational studyHealthy volunteers welcome
- University of Rochester NCORP Research Base, Rochester
Chronic Lymphocytic Leukemia trials in other cities
- Boston, MA31 studies
- Columbus, OH28 studies
- Durham, NC27 studies
- Washington, DC22 studies
- Seattle, WA20 studies
- Rochester, MN19 studies
- New York City, NY18 studies
- Houston, TX17 studies
- Baldwin Park, CA16 studies
- Milwaukee, WI15 studies
- Cincinnati, OH14 studies
- Chicago, IL14 studies
Other studies in Rochester
- Acute Myeloid Leukemia16 studies
- Lung Cancer15 studies
- Breast Cancer15 studies
- Cancer (all types)14 studies
- Obesity14 studies
- Non-Small Cell Lung Cancer13 studies
- Overweight13 studies
- Prostate Cancer10 studies
- Multiple Myeloma8 studies
- Metastatic Cancer8 studies
- Pancreatic Cancer7 studies
- Myotonic Dystrophy7 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.